Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • stianlagstad
    replied
    For anyone interested: They used dRanger (not publicly available) and Breakpointer in order to detect the fusion from exome data.

    Leave a comment:


  • sachin
    replied
    Originally posted by ymc View Post
    http://www.ncbi.nlm.nih.gov/pubmed/23313954

    This research says it did. Is it because the junction point lies with exons of both genes?
    Hi,
    Have you detected fusions using Exome tumor data?
    Thanks,
    Sachin

    Leave a comment:


  • ndaniel
    replied
    The answer is that it depends on:
    - where fusion junction point lies (it is "well" inside an exon which should be 'captured' properly and both genes involved in fusion should captured properly),
    - coverage of sequencing

    Whole genome sequencing and RNA-seq are ones of the most used for finding fusion genes and/or translocations.

    Leave a comment:


  • dpryan
    replied
    Sure, you can still pick up chromosomal and other structural rearrangements with exome sequencing, just not 100% of the time. You're correct that the reason this worked was due to the genes rearranging and effectively merging in the genome. Because of that, the capture kit still got reads that mapped to the end of one or the other of the genes (with the remainder mappable to the other gene).

    This would be in contrast to detecting fusion transcripts arising from neighboring genes being coexpressed and spliced together. Those sorts of situations wouldn't be detectable with exome sequencing.

    Leave a comment:


  • ymc
    started a topic exome sequencing can detect fusion genes?

    exome sequencing can detect fusion genes?

    Solitary fibrous tumors (SFTs) are rare mesenchymal tumors. Here, we describe the identification of a NAB2-STAT6 fusion from whole-exome sequencing of 17 SFTs. Analysis in 53 tumors confirmed the presence of 7 variants of this fusion transcript in 29 tumors (55%), representing a lower bound for fusi …


    This research says it did. Is it because the junction point lies with exons of both genes?

Latest Articles

Collapse

  • seqadmin
    Understanding Genetic Influence on Infectious Disease
    by seqadmin




    During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

    Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
    09-09-2024, 10:59 AM
  • seqadmin
    Addressing Off-Target Effects in CRISPR Technologies
    by seqadmin






    The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
    08-27-2024, 04:44 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 09-06-2024, 08:02 AM
0 responses
143 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-03-2024, 08:30 AM
0 responses
147 views
0 likes
Last Post seqadmin  
Started by seqadmin, 08-27-2024, 04:40 AM
0 responses
158 views
0 likes
Last Post seqadmin  
Started by seqadmin, 08-22-2024, 05:00 AM
0 responses
403 views
0 likes
Last Post seqadmin  
Working...
X